Colon, Sigmoid Clinical Trial
— LASEROfficial title:
LASER Trial. LAparoscopic Elective Sigmoid Resection Following divERticulitis - a Multicenter, Prospective, Randomized Clinical Trial
Verified date | August 2020 |
Source | Helsinki University Central Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to find out whether elective sigmoid resection will improve quality of life compared to conservative treatment with lifestyle guidance and fiber supplement in patients with a recurrent or complicated diverticulitis.
Status | Active, not recruiting |
Enrollment | 133 |
Est. completion date | December 2027 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Recurrent left colon diverticulitis (minimum 3 within 2 years, at least 1 confirmed with CT) OR - Earlier complicated left colon diverticulitis OR - Prolonged (over 3 months) pain or disturbance in bowel habits after a CT-confirmed left colon diverticulitis Exclusion Criteria: - Multimorbidity that prevents elective surgery - Contraindication to laparoscopy - Colonic stricture - Fistula (e.g. colocutaneous, colovaginal, colovesical) - Active malignancy - Earlier resection of sigmoid colon or rectum - Acute diverticulitis that has not settled - Colonoscopy/sigmoidoscopy/virtual colonoscopy not performed within 2 years - Age < 18 or > 75 years - Pregnancy - Inability to answer health surveys (e.g. dementia, psychiatric condition) |
Country | Name | City | State |
---|---|---|---|
Finland | Helsinki University Central Hospital, Jorvi Hospital | Espoo | |
Finland | Kanta-Häme Central Hospital | Hämeenlinna | |
Finland | Helsinki University Central Hospital | Helsinki | |
Finland | North Carelia Central Hospital | Joensuu | |
Finland | Keski-Suomi Central Hospital | Jyväskylä | |
Finland | Kuopio University Central Hospital | Kuopio | |
Finland | Päijät-Häme Central Hospital | Lahti | |
Finland | Oulu University Hospital | Oulu | |
Finland | Etelä-Pohjanmaa Central Hospital | Seinäjoki | |
Finland | Turku University Central Hospital | Turku | |
Finland | Vaasa Central Hospital | Vaasa |
Lead Sponsor | Collaborator |
---|---|
Helsinki University Central Hospital |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gastrointestinal quality of life-index change at 6 months | Difference in gastrointestinal quality of life-index (GIQLI) at randomization and 6 months from randomization. | 6 months from randomization | |
Secondary | GIQLI at 12, 24, 48, and 96 months | 12, 24, 48, and 96 months from randomization | ||
Secondary | Short form (SF) 36 Health survey score at 6, 12, 24, 48, and 96 months | 6, 12, 24, 48, and 96 months from randomization | ||
Secondary | Recurrence and severity of recurrent diverticulitis | 0 - 96 months from randomization | ||
Secondary | Need of emergency surgery due to diverticulitis | Whether or not patient has undergone emergency surgery due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records. | 0 - 96 months from randomization | |
Secondary | Need of elective sigmoid resection due to diverticulitis (conservative arm) | Whether or not patient has undergone elective sigmoid resection due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records. | 0 - 96 months from randomization | |
Secondary | Complications due to elective sigmoid resection | 0 - 96 months from randomization | ||
Secondary | Mortality | 0 - 96 months | ||
Secondary | Complications of diverticular disease | 0 - 96 months | ||
Secondary | Stoma rate | 0 - 96 months from randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01682395 -
Best Management of Sigmoid Volvulus: A Prospective Randomized Trial
|
N/A | |
Recruiting |
NCT02222844 -
Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
|
N/A |